Exencial Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29M | Buy |
32,714
+1,661
| +5% | +$116K | 0.08% | 202 |
|
|
2025
Q1 | $2.28M | Buy |
31,053
+6,885
| +28% | +$506K | 0.08% | 200 |
|
|
2024
Q4 | $1.58M | Buy |
+24,168
| New | +$1.58M | 0.06% | 239 |
|
|
2022
Q1 | – | Sell |
-5,606
| Closed | -$327K | – | 444 |
|
|
2021
Q4 | $327K | Buy |
5,606
+1,617
| +41% | +$94.3K | 0.02% | 372 |
|
|
2021
Q3 | $240K | Sell |
3,989
-795
| -17% | -$47.8K | 0.01% | 297 |
|
|
2021
Q2 | $287K | Sell |
4,784
-54
| -1% | -$3.24K | 0.02% | 383 |
|
|
2021
Q1 | $241K | Buy |
+4,838
| New | +$241K | 0.01% | 383 |
|
|
2020
Q4 | – | Sell |
-4,132
| Closed | -$226K | – | 370 |
|
|
2020
Q3 | $226K | Buy |
+4,132
| New | +$226K | 0.01% | 329 |
|